However, the authors suggested Panx1 as a potential pharmacological target in AKI and proposed several mechanisms of its renoprotective effect in the Panx1-deficient mice, including reduced inflammation with decreased cytokine and adhesion molecule expression and neutrophil infiltration [7]. Here, PANX1 is linked to acute kidney injury.